158 related articles for article (PubMed ID: 36603691)
1. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review.
Andriambelo B; Stiffel M; Roke K; Plourde M
Ageing Res Rev; 2023 Mar; 85():101835. PubMed ID: 36603691
[TBL] [Abstract][Full Text] [Related]
2. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
Welty FK; Daher R; Garelnabi M
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
4. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
[TBL] [Abstract][Full Text] [Related]
5. ω-3 fatty acids in the prevention of cognitive decline in humans.
Cederholm T; Salem N; Palmblad J
Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids and cognitive function.
Welty FK
Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
[TBL] [Abstract][Full Text] [Related]
7. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
[TBL] [Abstract][Full Text] [Related]
8. A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study.
Vauzour D; Scholey A; White DJ; Cohen NJ; Cassidy A; Gillings R; Irvine MA; Kay CD; Kim M; King R; Legido-Quigley C; Potter JF; Schwarb H; Minihane AM
Am J Clin Nutr; 2023 Aug; 118(2):369-381. PubMed ID: 37315924
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
[TBL] [Abstract][Full Text] [Related]
11. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636].
Dangour AD; Clemens F; Elbourne D; Fasey N; Fletcher AE; Hardy P; Holder GE; Huppert FA; Knight R; Letley L; Richards M; Truesdale A; Vickers M; Uauy R
Nutr J; 2006 Aug; 5():20. PubMed ID: 16945130
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA
Am J Clin Nutr; 2021 Sep; 114(3):914-924. PubMed ID: 34113957
[TBL] [Abstract][Full Text] [Related]
14. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
Sydenham E; Dangour AD; Lim WS
Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
[TBL] [Abstract][Full Text] [Related]
15. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
16. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news?
Cederholm T
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):104-109. PubMed ID: 27977429
[TBL] [Abstract][Full Text] [Related]
17. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
Cederholm T; Palmblad J
Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
[TBL] [Abstract][Full Text] [Related]
20. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.
Miller PE; Van Elswyk M; Alexander DD
Am J Hypertens; 2014 Jul; 27(7):885-96. PubMed ID: 24610882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
